Lexeo Therapeutics (LXEO) Net Equity Issued and Repurchased (2025 - 2026)
Lexeo Therapeutics (LXEO) posted Net Equity Issued and Repurchased of $143000.0 for Q1 2026, up 14400.0% sequentially from -$1000.0 in Q4 2025, and down 15.88% YoY from $170000.0 in Q1 2025.
Lexeo Therapeutics (LXEO) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $143000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 15.88% year-over-year to $143000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $243000.0 (changed N/A YoY) and the FY2025 annual result came in at $270000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to $143000.0 in Q1 2026 per LXEO's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $170000.0 in Q1 2025 and troughed at -$1000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | 25.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.00 Mn |
| Jun 30, 2026 | 25.00 Mn |
| Mar 31, 2026 | 143,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |